CRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Salesforce is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy. The stock has supportive long-term catalysts like AI products, buybacks, and a newly raised FY2027 revenue guide, but the current setup is mixed: the price is below key moving averages, analyst sentiment has cooled after Q1 earnings, and the latest quarter did not clearly prove a durable growth reacceleration. Since you are impatient and do not want to wait for an ideal entry, I would not press a full buy here. The better call is to hold and wait for a cleaner trend or clearer revenue acceleration.
CRM closed at 176.89, slightly above the pivot at 176.23, but the broader trend remains weak. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, showing the stock is still in a longer-term downtrend or recovery phase. MACD histogram is positive at 0.371 but contracting, which suggests momentum is improving only modestly. RSI_6 at 44.687 is neutral and does not signal oversold strength. Key levels: resistance at 185.06 and 190.51, support at 167.40 and 161.95. Overall, price action is range-bound and not yet in a confirmed uptrend.
["Salesforce raised fiscal year 2027 revenue guidance to $45.9B-$46.2B.", "The company declared a quarterly dividend of $0.44 per share, supporting shareholder returns.", "Management continues to point to second-half growth acceleration from Agentforce, Data, and Slack pipelines.", "Congress trading data shows more buying than selling, with 5 purchase transactions versus 1 sale transaction.", "Some analysts remain bullish, with TD Cowen, Roth Capital, and Baird maintaining Buy/Outperform ratings."]
["Q2 revenue guidance of about $11.3B came in below analyst expectations.", "Several analysts cut price targets after earnings, showing reduced confidence in near-term upside.", "Revenue growth has been described as weak for about two years, with only partial evidence of reacceleration.", "The stock remains in a bearish technical structure below key moving averages.", "News flow suggests investors are still unconvinced the AI transition will quickly lift the core software business."]
No full financial snapshot was provided because of an error, but the latest quarter referenced is Q1 FY2027. The quarter was generally mixed: earnings were viewed as decent, organic growth was around 7% constant currency, and management raised FY2027 revenue guidance. However, the Q2 revenue outlook missed expectations, so the latest quarter did not clearly show strong top-line acceleration. The main positive is improving EPS support from buybacks and cost control, but revenue growth remains the key weak spot.
Analyst sentiment is mixed to cautious after Q1 earnings. Several firms lowered price targets, including Northland, BMO, TD Cowen, DA Davidson, Citi, Wells Fargo, Bernstein, and Baird. Ratings were split between Buy/Outperform and Neutral/Underperform, with Bulls emphasizing AI and expected second-half acceleration, while Bears focused on decelerating growth and weaker guidance. Wall Street’s overall view is that CRM is not expensive, but the market needs clearer proof of sustained revenue reacceleration before rating upgrades become more convincing. Net view: cautious constructive, but not a strong consensus buy.
